|
Volumn 55, Issue 5, 2016, Pages 902-910
|
Phenotypic variability in patients with ADA2 deficiency due to identical homozygous R169Q mutations
a a b b c c c d d e e a,f g b b b b a h a more.. |
Author keywords
ADA2; Auto inflammatory disease; CECR1; Early onset stroke; Genotype; Livedo reticularis; Phenotype; Vasculitis
|
Indexed keywords
ACETYLSALICYLIC ACID;
ADALIMUMAB;
ADENOSINE DEAMINASE;
ADENOSINE DEAMINASE 2;
RECOMBINANT INTERLEUKIN 1 RECEPTOR BLOCKING AGENT;
UNCLASSIFIED DRUG;
ACUTE MYELOBLASTIC LEUKEMIA;
ADENOSINE DEAMINASE 2 DEFICIENCY;
ADENOSINE DEAMINASE DEFICIENCY;
ADOLESCENT;
ADULT;
ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION;
APLASTIC ANEMIA;
ARTICLE;
CEREBROVASCULAR ACCIDENT;
CHILD;
CLINICAL ARTICLE;
CONTROLLED STUDY;
CORRELATIONAL STUDY;
CYTOPENIA;
ENZYME ACTIVITY;
FOLLOW UP;
FOUNDER EFFECT;
GENE FREQUENCY;
GENE IDENTIFICATION;
GENETIC VARIABILITY;
GENOTYPE PHENOTYPE CORRELATION;
HAPLOTYPE;
HEPATOSPLENOMEGALY;
HUMAN;
IMMUNOGLOBULIN DEFICIENCY;
LOW DRUG DOSE;
MUTATOR GENE;
NUCLEAR MAGNETIC RESONANCE IMAGING;
OUTCOME ASSESSMENT;
PRESCHOOL CHILD;
PRIORITY JOURNAL;
R169Q GENE;
SCHOOL CHILD;
SKIN ULCER;
YOUNG ADULT;
|
EID: 84965060479
PISSN: 14620324
EISSN: 14620332
Source Type: Journal
DOI: 10.1093/rheumatology/kev439 Document Type: Article |
Times cited : (127)
|
References (11)
|